Prescription Drugs Market Research Reports & Industry Analysis
The prescription drugs industry is a key cornerstone of healthcare, delivering vital medications that improve and save lives. As this industry continues to evolve, understanding its nuances can be an ongoing challenge. MarketResearch.com provides hundreds of authoritative prescription drugs market research reports to help stakeholders understand the shifting market landscape and devise effective business strategies.
The Latest Prescription Drugs Market Analysis
- We provide data-packed reports on a wide range of product types, therapeutic areas, regions, and companies.
- Our research includes in-depth analyses of prescription drug market size, growth forecasts, and drivers and challenges.
- In addition, we cover the rise of personalized medicine and gene therapies, as well as regulatory issues and pricing models.
Your Dedicated Research Partner
As the prescription drugs industry shifts and changes, MarketResearch.com equips you with the tools to thrive. Trusted for decades as a reliable research partner, our clients include top pharmaceutical companies, investment banks, and universities. Whether you are exploring new markets or seeking to futureproof your business, our prescription drugs industry research reports offer a wealth of knowledge to inform your strategy. Get started by exploring our vast selection of reports on the prescription drugs industry today.
Prescription Drugs Industry Research & Market Reports
-
Hirsutism Treatment
... at a CAGR of 5.0% over the analysis period 2023-2030. Hirsutism Medications, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$2.4 Billion by the end of ... Read More
-
Growth Hormone Deficiency Market Size, Share & Segmentation, by Type, by Indication, by Distribution Channel, By Regions | Global Market Forecast 2024-2031
... insights into a specific market, industry, or sector. It involves the systematic collection, analysis, and interpretation of data related to market conditions, consumer behaviors, competitive landscapes, and emerging trends. The primary purpose of a market ... Read More
-
Drug Abuse Testing Market Report By Drug Type (Opioids, Cocaine, Alcohol, Cannabis/Marijauna, Amphetamine & Methaphetamine, LSD, Others), Product & Services (Consumables, Analysers, Rapid Testing Devices, Laboratory Services), Sample Type (Breath, Hair, Urine, Oral Fluid, Others), End Users (Rehabilitation Centers, Drug Testing Laboratories, Workplaces, Hospitals, Academic Institutes and Research Centers, Others) Countries and Company Analysis 2024-2032
... End Users (Rehabilitation Centers, Drug Testing Laboratories, Workplaces, Hospitals, Academic Institutes and Research Centers, Others) Countries and Company Analysis 2024-2032 Global Drug Abuse Testing Market Analysis Drug Abuse Testing Market will attain US$ 11.87 billion ... Read More
-
Doxorubicin
... of 5.8% over the analysis period 2023-2030. Breast Cancer Application, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$374.1 Million by the end of the analysis ... Read More
-
Global Osteoporosis Drugs Market Report by Route of Administration (Injectable, Oral, Others) Product Type (Rank Ligand Inhibitor, Bisphosphonates, Calcitonin, Parathyroid Hormone Therapy (PTH), Selective Estrogen Receptor Modulators (SERMs), Sclerostin Inhibitor, Others) Countries and Company Analysis, 2024-2032
... 2024-2032 Osteoporosis Drugs Market Analysis The osteoporosis drugs market is expected to over US$ 25.53 billion by 2032 from US$ 17.43 billion by 2023, with a CAGR growth of 4.33% from 2024 to 2032 because ... Read More
-
United States Pain Management Therapeutics Market and Forecast Therapeutics (Devices and Pharmaceuticals), Pain Type, Drug Class, Indication, Distribution Channel and Company Analysis 2024-2032
... Therapeutics Market will reach US$ 36.15 billion by 2032, up from US$ 26.18 billion in 2023, with a CAGR of 3.65% between 2024 and 2032. Many factors are driving the market's rapid expansion such as ... Read More
-
Anti-Infectives
... of 6.2% over the analysis period 2023-2030. Anti-Viral Drugs, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$117.1 Billion by the end of the analysis period. ... Read More
-
Global Antacids Market Report by Formulation Type (Powder, Tablets, Liquid, Others) Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) Drug Class (Acid Neutralizers, Proton Pump Inhibitors, H2 Antagonist, Pro-Motility Agents) Countries and Company Analysis, 2024-2032
... Global Antacids Market Size Global antacids Market will be expected to cross US$ 9.70 billion by 2032 with a CAGR of 3.89 from 2024 to 2032. This growth has been fostered by the rising incidence ... Read More
-
Kidney Cancer Drugs
... by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$5.6 Billion by ... Read More
-
Herpes Simplex Virus Infections
... reach US$6.6 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2023-2030. The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 6.6% CAGR The Herpes ... Read More
-
Women's Health Therapeutics
... Billion by 2030, growing at a CAGR of 12.7% over the analysis period 2023-2030. Postmenopausal Osteoporosis Application, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach US$18.1 ... Read More
-
Xerostomia (Dry Mouth) Therapeutics
... reach US$1.0 Billion by 2030, growing at a CAGR of 3.9% over the analysis period 2023-2030. Over-the-Counter Xerostomia Drugs, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and ... Read More
-
Cardiovascular Drugs
... at a CAGR of 3.5% over the analysis period 2023-2030. Anticoagulants, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$57.7 Billion by the end of the ... Read More
-
Lung Cancer Therapeutics
... by 2030, growing at a CAGR of 10.9% over the analysis period 2023-2030. Non-Small-Cell Lung Cancer (NSCLC) Therapeutics, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach ... Read More
-
Rheumatoid Arthritis Therapeutics
... by 2030, growing at a CAGR of 4.1% over the analysis period 2023-2030. Pharmaceuticals Molecule, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$28.0 Billion by ... Read More
-
Anxiety Disorder Treatment
... by 2030, growing at a CAGR of 2.4% over the analysis period 2023-2030. Antidepressants, one of the segments analyzed in the report, is expected to record a 3.0% CAGR and reach US$4.9 Billion by the ... Read More
-
Hepatitis C Treatment
... by 2030, growing at a CAGR of 10.9% over the analysis period 2023-2030. HCV Protease Inhibitors Drug Class, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach ... Read More
-
Europe Synthetic Hormones Market: Focus on Product Type, Route of Administration, Application, End User, and Country - Analysis and Forecast, 2023-2033
... at $4.90 billion in 2023 and is expected to reach $10.53 billion by 2033, growing at a CAGR of 7.94% during the forecast period 2023-2033. The synthetic hormones market is advancing due to significant developments ... Read More
-
Europe Highly Potent API Market - Analysis and Forecast, 2023-2033
... 2023, growing at a CAGR of 10.57% during the forecast period 2023-2033. The primary factors propelling the expansion of the highly potent API market are the rising incidence of cancer, which boosts the demand for ... Read More
-
Global Opioids Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... is forecast to a readjusted size of USD 14810 million by 2030 with a CAGR of 5.3% during review period. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such ... Read More
-
China Online Healthcare Market: Insights & Forecast with Potential Impact of COVID-19 (2024-2028)
... spanning from 2024 to 2028. Growth in China online healthcare market is supported by factors such as aging population, rising health expenditure, support from Chinese government, technical innovations and rising internet penetration. However, the market ... Read More
-
US Oral Antiviral Market Size study, by Indication (Hepatitis, Human Immunodeficiency Virus (HIV), Influenza, Others) by Drug Class (Protease inhibitors, Reverse transcriptase inhibitors, Others) by Distribution Channel (Hospital pharmacies, Drug store and retail pharmacies, Online providers) Forecasts 2022-2032
... providers) Forecasts 2022-2032 US Oral Antiviral Market is valued approximately USD 9.98 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 1.69% over the forecast period 2024-2032. Oral ... Read More
-
Global Oral Antiviral Market Size study, by Indication (Hepatitis, Human Immunodeficiency Virus (HIV), Influenza, Others) by Drug Class (Protease inhibitors, Reverse transcriptase inhibitors, Others) by Distribution Channel (Hospital pharmacies, Drug store and retail pharmacies, Online providers) and Regional Forecasts 2022-2032
... providers) and Regional Forecasts 2022-2032 Global Oral Antiviral Market is valued approximately USD 36.7 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 2.10% over the forecast period ... Read More
-
Substance (Drug) Abuse - Global Clinical Trials Review, 2024
... of Substance (Drug) Abuse Clinical trials scenario. This report provides top line data relating to the clinical trials on Substance (Drug) Abuse. Report includes an overview of trial numbers and their average enrollment in top ... Read More
-
Osteoporosis: Seven-Market Drug Forecast and Market Analysis
... as a systemic skeletal disease characterized by low bone mass and micro-architectural deterioration of bone tissue, predisposing a person to bone fragility and susceptibility to fracture. Common sites of fracture include the spine, hip, distal ... Read More
Research Assistance
